📰 Giveni Mab News
Giveni Mab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Giveni Mab. Real-time updates on events, politics, business and more.
January 10, 2024
I-Mab (NASDAQ:IMAB – Get Free Report) and Cerevel Therapeutics (NASDAQ:CERE – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 22.6% of I-Mab shares are […]
June 19, 2023
I-Mab (NASDAQ:IMAB – Get Rating) and Xilio Therapeutics (NASDAQ:XLO – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations and profitability. Analyst Recommendations This is a breakdown of recent recommendations and […]
June 17, 2023
I-Mab (NASDAQ:IMAB – Get Rating) and Xilio Therapeutics (NASDAQ:XLO – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation. Valuation and Earnings This table compares I-Mab and Xilio Therapeutics’ […]
June 10, 2022
I-Mab (NASDAQ:IMAB – Get Rating) and Galera Therapeutics (NASDAQ:GRTX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership. Valuation and Earnings This table compares I-Mab and Galera Therapeutics’ […]
March 23, 2022
Iterum Therapeutics (NASDAQ:ITRM – Get Rating) and I-Mab (NASDAQ:IMAB – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Profitability This table compares Iterum Therapeutics and I-Mab’s net margins, […]
March 23, 2022
I-Mab (NASDAQ:IMAB – Get Rating) and Iterum Therapeutics (NASDAQ:ITRM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations. Risk & Volatility I-Mab has a beta of 0.94, indicating […]